Medimix Hematology
  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
EHA 2023

José Carreras Award: Ph+ ALL, from the worst malignancy to a chemo/transplant-free management

June 9, 2023

Prof. Robin Foà, a distinguished hematology professor at the Sapienza University of Rome, Italy, was honoured with the prestigious José Carreras Award for his significant contributions to the field of hematology research.

In an exclusive interview with MediMix, Prof. Foà shared his invaluable insights into his ground-breaking research on Ph+ ALL many years ago and the remarkable advancements in modern management options. 

With the educational support of:

Tags:

in-depth

Share Article

Medimix Hematology

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok